MAUREEN MCLAUGHLIN: Open Payments
NPI 1992074843 · SPRING HOUSE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 50 payments from 13 companies in 2025. Trend: 2023 $900 · 2024 $889 · 2025 $966
Food & beverage: $894Education: $72
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $195 |
| Janssen Biotech, Inc. | 9 | $187 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $170 |
| Regeneron Healthcare Solutions, Inc. | 4 | $90 |
| E.R. Squibb & Sons, L.L.C. | 4 | $75 |
| Amgen Inc. | 3 | $62 |
| Incyte Corporation | 2 | $47 |
| Lilly USA, LLC | 2 | $29 |
| Organon LLC | 2 | $28 |
| UCB, Inc. | 1 | $26 |
Products named: TREMFYA, SKYRIZI, Sotyktu, LIBTAYO, ILUMYA, OTEZLA, OPZELURA, DUPIXENT.
Industry payments across PA — which companies pay providers there.
